Norwood Connor W, Wright Eric R
Indiana University, Richard M. Fairbanks School of Public Health, 714 N. Senate Ave., Indianapolis, IN 46202, USA; Center for Health Policy, Indiana University Purdue University - Indianapolis, 714 N. Senate Ave., Indianapolis, IN 46202, USA; Health Workforce Studies, Department of Family Medicine, Indiana University School of Medicine, 1110 W. Michigan St., Long Hall 200, Indianapolis, IN 46202, USA.
Indiana University, Richard M. Fairbanks School of Public Health, 714 N. Senate Ave., Indianapolis, IN 46202, USA; Center for Health Policy, Indiana University Purdue University - Indianapolis, 714 N. Senate Ave., Indianapolis, IN 46202, USA; Georgia State University, Department of Sociology, 38 Peachtree Center Ave. SE, Langdale Hall Suite 1061, Atlanta, GA 30303, USA.
Res Social Adm Pharm. 2016 May-Jun;12(3):509-14. doi: 10.1016/j.sapharm.2015.07.008. Epub 2015 Aug 7.
Prescription drug monitoring programs (PDMPs) are proving to be valuable resources in fighting the prescription drug abuse epidemic through improved access to patient drug histories. Ninety-four percent of Indiana pharmacists have heard of Indiana's PDMP (INSPECT), only 71% of them reported using the program in 2012.
To identify barriers to PDMP use in outpatient pharmacies and determine the impact these barriers have on utilization.
A cross-sectional study examined pharmacists' knowledge and use of INSPECT. Bivariate analyses on utilization and perceived barriers were conducted using cross-tabulations and chi-squared tests. Multiple logistic regression examined the relationship between pharmacists' level of concern with prescription drug abuse and reported utilization.
Pharmacists were significantly less likely to use INSPECT if they reported at least one barrier and 3 times more likely to use INSPECT if they reported no barrier. Pharmacists were 10 times more likely to use INSPECT and 18 times more likely to use it more consistently if they were extremely concerned about prescription drug abuse in their community as compared to those not at all concerned.
Strategies to improve utilization of PDMPs should look for innovative ways to limit barriers and build outpatient pharmacists' awareness of prescription drug abuse and misuse within their community.
通过改善获取患者用药史的途径,处方药监测计划(PDMPs)已被证明是抗击处方药滥用流行的宝贵资源。94%的印第安纳州药剂师听说过印第安纳州的PDMP(INSPECT),但在2012年,只有71%的药剂师报告使用了该计划。
确定门诊药房使用PDMP的障碍,并确定这些障碍对其使用的影响。
一项横断面研究调查了药剂师对INSPECT的了解和使用情况。使用交叉表和卡方检验对使用情况和感知到的障碍进行双变量分析。多元逻辑回归分析了药剂师对处方药滥用的关注程度与报告的使用情况之间的关系。
如果药剂师报告至少一个障碍,他们使用INSPECT的可能性显著降低;如果他们报告没有障碍,使用INSPECT的可能性则会增加3倍。与那些完全不担心社区处方药滥用问题的药剂师相比,如果药剂师对所在社区的处方药滥用问题极为关注,他们使用INSPECT的可能性高出10倍,且更持续使用的可能性高出18倍。
提高PDMPs利用率的策略应寻求创新方法,以减少障碍,并提高门诊药剂师对所在社区处方药滥用和误用问题的认识。